Advertisement

Topics

Lilly USA Company Profile

06:44 EDT 21st June 2018 | BioPortfolio

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. For additional information on Health Education Answers or Lilly's other patient care and disease management programs, visit www.lillyforbetterhealth.com.


News Articles [510 Associated News Articles listed on BioPortfolio]

Lilly To Acquire AurKa Pharma

NewsThe acquisition expands Lilly oncology pipeline with early-phase asset being studied in multiple tumor types.

M&As this week: Eli Lilly, Fujifilm Holdings, Canopy Growth

US-based healthcare company Eli Lilly and Company has agreed to acquire AurKa Pharma Inc. Eli Lilly will purchase all shares of...Read More... The post M&As this week: Eli Lilly, Fujifilm Holding...

Eli Lilly: The Issues With Drug Development and Regaining the Public's Trust

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Gino Santini, Vice President, Corporate Strategy, at Eli Lilly. Filmed at BIO-Europe 2009, they discuss: • Eli Lilly's CEO's ...

Versicor Licenses Fungicidal Agent from Eli Lilly and Co.

Versicor Inc. (Fremont, CA) and Eli Lilly and Co. (Indianapolis) have entered into licensing agreement under which Versicor will receive exclusive worldwide rights to LY303366, Lilly's semi-synthetic ...

Eli Lilly’s Olumiant: how will it far among JAK inhibitors?

On June 1, Eli Lilly’s Olumiant (baricitinib) 2mg tablets received FDA approval for adult patients with moderately to severely active...Read More... The post Eli Lilly’s Olumiant: how will it far ...

STAT Plus: Eli Lilly acquires small biotech for $1.6B to strengthen cancer immunotherapy pipeline

Eli Lilly and Co. is buying a small biotech developing a new type of drug that stimulates the immune system to kill cancer. In a deal announced Thursday, Lilly said…

Lilly’s arthritis drug hits trouble at FDA committee

FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the treatment of rheumatoid arthritis (RA). The drug had initially bee...

Eli Lilly & Co.: Partnering in Europe: Lilly's Take on the Landscape

In this exclusive interview, live from Geneva, Fintan Walton talks to Andrew Wood, Executive Director, Global External R&D Europe at Eli Lilly & Co. They start by talking about Andrew’s function wit...

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Humulin [Eli Lilly and Company]

HUMULIN N NPH HUMAN INSULIN (rDNA ORIGIN)ISOPHANE SUSPENSION100 UNITS PER ML (U-100)

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds.

For the manufacture of small molecule drugs, many pharmaceutical innovator companies have recently invested in continuous processing, which can offer significant technical and economic advantages over...

The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.

Lilly/Avid's AV-1451 is one of the most advanced tau PET tracers in the clinic. Although results obtained in Alzheimer's disease patients are compelling, discrimination of tracer uptake in healthy ind...

Abemaciclib: First Global Approval.

Abemaciclib (Verzenio™) is an orally administered inhibitor of cyclin-dependent kinases 4 and 6 that is being developed by Eli Lilly and Company. Abemaciclib has been approved in the USA for the tre...

Clinical Trials [26 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

This is a non-inferiority, multi-center, randomized, controlled, single-blind, two-way crossover efficacy and safety study in subjects with Type 1 diabetes mellitus. The study involves two...

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

This study aims to assess the effects of early basal insulin therapy in previously non-diabetic de novo kidney transplant patients in reducing the incidence of new onset diabetes in partic...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Companies [55 Associated Companies listed on BioPortfolio]

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly USA, LLC

More Information about "Lilly USA" on BioPortfolio

We have published hundreds of Lilly USA news stories on BioPortfolio along with dozens of Lilly USA Clinical Trials and PubMed Articles about Lilly USA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lilly USA Companies in our database. You can also find out about relevant Lilly USA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record